Global Nicotinamide Riboside Supplements Market Size, Share, and COVID-19 Impact Analysis, By Product Form (Capsules, Tablets, Powders, and Others), By Application (Dietary Supplements, Pharmaceuticals, Functional Food & Beverages, and Others), By Distribution Channel (Online Stores, Pharmacies, Supermarkets/Hypermarkets, Specialty Stores, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Nicotinamide Riboside Supplements Market Insights Forecasts to 2035

• The Global Nicotinamide Riboside Supplements Market Size Was Estimated at USD 591.0 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 13.17% from 2025 to 2035
• The Worldwide Nicotinamide Riboside Supplements Market Size is Expected to Reach USD 2305.0 Million by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, the global nicotinamide riboside supplements market size was worth around USD 591.0 million in 2024 and is predicted to grow to around USD 2305.0 million by 2035 with a compound annual growth rate (CAGR) of 13.17% from 2025 and 2035. The market for nicotinamide riboside supplements has a number of opportunities to grow due to the emerging role of nicotinamide riboside in health and disease.

Market Overview

The Nicotinamide Riboside Supplements Market Size refers to a growing sector of the dietary supplement industry, driven by increased consumer awareness of cellular health and the anti-ageing benefits of NAD+. Nicotinamide riboside is a form of vitamin B3, commonly marketed as an anti-ageing product due to the NAD+ molecule made by the conversion of nicotinamide ribose, supporting many aspects of healthy ageing and promoting healthy ageing. The nicotinamide riboside supplements, as a nutraceutical aid in promoting cardiometabolic and musculoskeletal health by enhancing NAD+ biosynthesis, mitochondrial function, and/or activities of NAD-dependent sirtuin deacetylase enzymes.

Innovation and market expansion are anticipated as a result of major players' growing R&D expenditures and the expanding partnerships for promoting global wellness. For instance, in May 2024, NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd. have officially entered into a dynamic strategic partnership to collaboratively focus on the future of global health and wellness.    

Report Coverage

This research report categorizes the nicotinamide riboside supplements market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the nicotinamide riboside supplements market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the nicotinamide riboside supplements market. 

Driving Factors

An increasing health consciousness and prevalence of metabolic disorders primarily drive the nicotinamide riboside supplements market. Nicotinamide riboside is considered a potent NAD+ enhancement agent, which plays an important role in promoting anti-ageing effects. It has further demonstrated excellent safety and efficacy profiles with good oral bioavailability, which is responsible for driving the market demand. Further, its demand is rising in functional foods and drinks due to its NAD+ boosting capability, by the use of nicotinamide riboside as a vitamin B3 precursor.

Restraining Factors

Regulatory obstacles and the increased cost of nicotinamide riboside supplements restrict the nicotinamide riboside supplements market. Further, the lack of clinical evidence and limited consumer awareness regarding the efficacy of NR products are restricting the market growth.

Market Segmentation

The nicotinamide riboside supplements market share is classified into product form, application, and distribution channel.   

• The capsules segment dominated the market with the largest share of about 36.2% in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the product form, the nicotinamide riboside supplements market is divided into capsules, tablets, powders, and others. Among these, the capsules segment dominated the market with the largest share of about 36.2% in 2024 and is projected to grow at a substantial CAGR during the forecast period. For instance, Doublewood Supplements NAD+, available in capsule form, functions to support NAD levels, thereby supporting cellular function. Consumers’ changing inclination towards capsules owing to their straightforward administration and precise dosage capabilities is driving the segmental market growth.

• The dietary supplements segment is dominating the nicotinamide riboside supplements market in 2024 and is anticipated to grow at a significant CAGR of about 10% during the projected period.

Based on the application, the nicotinamide riboside supplements market is divided into dietary supplements, pharmaceuticals, functional food & beverages, and others. Among these, the dietary supplements segment is dominating the nicotinamide riboside supplements market in 2024 and is anticipated to grow at a significant CAGR of about 10% during the projected period. Nucleoside riboside is suggested as a dietary supplement for improving fetal growth under hypoglycemia, due to its glucose metabolic function. Nicotinamide riboside supplements are marketed as dietary supplements due to their potential to boost cellular energy, support healthy ageing, and enhance metabolic function.

• The online stores segment accounted for the dominant market share of about 36% in 2024 and is anticipated to grow at a significant CAGR of over 9% during the forecast period.

Based on the distribution channel, the nicotinamide riboside supplements market is divided into online stores, pharmacies, supermarkets/hypermarkets, specialty stores, and others. Among these, the online stores segment accounted for the dominant market share of about 36% in 2024 and is anticipated to grow at a significant CAGR of over 9% during the forecast period. Amazon.in, PharmEasy, Healthkart, and Netmeds are some of the e-commerce platforms that offer a wide variety of supplements, including nicotinamide riboside supplements. With the rising e-commerce sector, the convenience of home delivery, detailed product information, and customer reviews provided by online platforms are contributing to driving the market.

Regional Segment Analysis of the Nicotinamide Riboside Supplements Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the nicotinamide riboside supplements market over the predicted timeframe.

North America is anticipated to hold the largest share of about 33.5% in the nicotinamide riboside supplements market over the predicted timeframe. The market ecosystem in North America is strong, with both FoodTech startups and major nutraceutical companies well-represented. The demand for nicotinamide riboside supplements has been driven by the region's increasing ageing population and surging preventive healthcare approaches. Further, an increasing clinical trials on nicotinamide riboside supplementation for improving long COVID symptoms is contributing to driving the market growth. The U.S. is leading the nicotinamide riboside supplements market in the North America region, accounting for a major regional share of about 80%, due to the integration of NAD+ optimization into wellness and precision nutrition programs, along with an inclination towards longevity-focused health solutions.

Asia Pacific is expected to grow at a rapid CAGR of 15.8% in the nicotinamide riboside supplements market during the forecast period. The Asia Pacific area has a thriving market for nicotinamide riboside supplements due to the region’s increasing disposable income, health awareness, and inclination towards preventive healthcare solutions. For instance, in April 2020, ChromaDex Corp. announced the exclusive launch of its new Tru Niagen Beauty cellular health and beauty daily supplement with Watsons Hong Kong, available online and in all Watsons stores. The strategic alliance for commercializing the nicotinamide riboside supplement products, along with increasing investment, is supporting market growth. China is the dominating country in the Asia Pacific nicotinamide riboside supplements market, fueled by an ongoing technological innovation, awareness of health supplements, and biotechnological advancements.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the nicotinamide riboside supplements market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Niagen Bioscience Inc.
• Thorne Research
• Double Wood Supplements
• Elysium Health
• H.V.L. Laboratories
• Life Extension
• NOW Foods
• Swanson Health Products
• GeneHarbor Technologies
• Jarrow Formulas
• Pure Encapsulations
• Nutricost
• Doctor's Best
• Biosynth Carbosynth
• Herbalmax
• Vital Nutrients
• Solgar
• Nature's Way
• Klaire Labs
• BulkSupplements.com
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In November 2025, Niagen Bioscience, Inc., the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy ageing, announced the launch of Tru Niagen Beauty, the first-ever beauty supplement in the US featuring Niagen (patented nicotinamide riboside or NR), the most efficient, effective, and high-quality NAD+ booster available.

• In March 2025, Niagen Bioscience, Inc., the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, confirmed it has changed its corporate name to Niagen Bioscience, Inc., and the Company’s common stock will begin trading under the new Nasdaq symbol “NAGE” on the stock market.  

• In October 2022, ChromaDex Corp., a global bioscience company, announced it had established a joint venture through its wholly owned subsidiary ChromaDex Asia Pacific Ventures Limited.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the nicotinamide riboside supplements market based on the below-mentioned segments:  

Global Nicotinamide Riboside Supplements Market, By Product Form  

• Capsules
• Tablets
• Powders
• Others

Global Nicotinamide Riboside Supplements Market, By Application

• Dietary Supplements
• Pharmaceuticals
• Functional Food & Beverages
• Others

Global Nicotinamide Riboside Supplements Market, By Distribution Channel

• Online Stores
• Pharmacies
• Supermarkets/Hypermarkets
• Specialty Stores
• Others

Global Nicotinamide Riboside Supplements Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa